v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning Balance, Values at Dec. 31, 2024 $ 293,105 $ 109 $ 1,003,685 $ 10 $ (710,699)
Beginning Balance, Shares at Dec. 31, 2024   109,381,556      
Exercise of stock options 62   62    
Exercise of stock options, Shares   43,113      
Restricted stock vested in the period   289,735      
Stock-based compensation 5,078   5,078    
Other comprehensive loss (101)     (101)  
Net loss (54,356)       (54,356)
Ending Balance, Values at Mar. 31, 2025 243,788 $ 109 1,008,825 (91) (765,055)
Ending Balance, Shares at Mar. 31, 2025   109,714,404      
Beginning Balance, Values at Dec. 31, 2024 293,105 $ 109 1,003,685 10 (710,699)
Beginning Balance, Shares at Dec. 31, 2024   109,381,556      
Net loss (103,512)        
Ending Balance, Values at Jun. 30, 2025 199,017 $ 110 1,013,211 (93) (814,211)
Ending Balance, Shares at Jun. 30, 2025   109,832,147      
Beginning Balance, Values at Mar. 31, 2025 243,788 $ 109 1,008,825 (91) (765,055)
Beginning Balance, Shares at Mar. 31, 2025   109,714,404      
Issuance of common stock per Employee Stock Purchase Plan purchase, Value 182 $ 1 181    
Issuance of common stock per Employee Stock Purchase Plan purchase, Shares   117,743      
Stock-based compensation 4,205   4,205    
Other comprehensive loss (2)     (2)  
Net loss (49,156)       (49,156)
Ending Balance, Values at Jun. 30, 2025 199,017 $ 110 1,013,211 (93) (814,211)
Ending Balance, Shares at Jun. 30, 2025   109,832,147      
Beginning Balance, Values at Dec. 31, 2025 211,648 $ 149 1,128,917 (29) (917,389)
Beginning Balance, Shares at Dec. 31, 2025   149,362,800      
Exercise of stock options 229   229    
Exercise of stock options, Shares   61,306      
Restricted stock vested in the period   501,341      
Issuance of common stock, net of issuance costs, Value 32,694 $ 6 32,688    
Issuance of common stock, net of issuance costs, Shares   6,049,762      
Exercise of pre-funded warrants, Value   $ 7 (7)    
Exercise of pre-funded warrants, Shares   6,526,508      
Stock-based compensation 4,156   4,156    
Other comprehensive loss (52)     (52)  
Net loss (44,142)       (44,142)
Ending Balance, Values at Mar. 31, 2026 204,533 $ 162 1,165,983 (81) (961,531)
Ending Balance, Shares at Mar. 31, 2026   162,501,717      
Beginning Balance, Values at Dec. 31, 2025 $ 211,648 $ 149 1,128,917 (29) (917,389)
Beginning Balance, Shares at Dec. 31, 2025   149,362,800      
Exercise of stock options, Shares 240,970        
Net loss $ (99,490)        
Ending Balance, Values at Jun. 30, 2026 186,061 $ 175 1,202,847 (82) (1,016,879)
Ending Balance, Shares at Jun. 30, 2026   174,604,198      
Beginning Balance, Values at Mar. 31, 2026 204,533 $ 162 1,165,983 (81) (961,531)
Beginning Balance, Shares at Mar. 31, 2026   162,501,717      
Exercise of stock options 564 $ 1 563    
Exercise of stock options, Shares   179,664      
Issuance of common stock, net of issuance costs, Value 31,013 $ 6 31,007    
Issuance of common stock, net of issuance costs, Shares   5,734,361      
Exercise of pre-funded warrants, Value   $ 6 (6)    
Exercise of pre-funded warrants, Shares   5,998,871      
Issuance of common stock per Employee Stock Purchase Plan purchase, Value 487   487    
Issuance of common stock per Employee Stock Purchase Plan purchase, Shares   189,585      
Stock-based compensation 4,813   4,813    
Other comprehensive loss (1)     (1)  
Net loss (55,348)       (55,348)
Ending Balance, Values at Jun. 30, 2026 $ 186,061 $ 175 $ 1,202,847 $ (82) $ (1,016,879)
Ending Balance, Shares at Jun. 30, 2026   174,604,198